Sort
141,003 grants matching “cytokine”
The Role of Vascular MR-Regulated Genes in Vascular Function and Disease
$784,522Iris Z Jaffe · Tufts Medical Center · R01 · FY2021 · HL
The Role of Vascular MR-Regulated Genes in Vascular Function and Disease
$784,522Iris Z Jaffe · Tufts Medical Center · R01 · FY2022 · HL
Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesis
$784,482Jonathan S Lewin · Emory University · P51 · FY2021 · OD
Project 3: Intraarticular Mineralization
$784,477Tuhina Neogi · Boston University Medical Campus · U19 · FY2024 · AG
Project 2: Development of Small Molecule Inhibitors of IL-17A Pathway for Treatment of Severe Asthma
$784,421Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru · P01 · FY2020 · HL
Project 2: Development of Small Molecule Inhibitors of IL-17A Pathway for Treatment of Severe Asthma
$784,421Xiaoxia Li · Cleveland Clinic Lerner Com-Cwru · P01 · FY2019 · HL
Impact of Cellular and Extracellular Host Components on Tumor Progression
$784,417Richard O Hynes · Massachusetts Institute Of Technology · U54 · FY2011 · CA
Ancillary Study: Identification of Plasma Biomarkers in COPD
$784,389Steven G Kelsen · Temple Univ Of The Commonwealth · RC2 · FY2009 · HL
Post-transcriptional modification in esophageal basal cells.
$784,280Jianwen Que · Columbia University Health Sciences · R01 · FY2025 · DK
Modulation of innate and adaptive immunity of filoviruses in macaques
$784,263Thomas William Geisbert · Icahn School Of Medicine At Mount Sinai · U19 · FY2015 · AI
Role of TNF receptor 2 on Pulmonary Group 2 Innate Lymphoid Cells
$784,241Omid Akbari · University Of Southern California · R01 · FY2023 · HL
Role of TNF receptor 2 on Pulmonary Group 2 Innate Lymphoid Cells
$784,241Omid Akbari · University Of Southern California · R01 · FY2022 · HL
Macrophages in Myocardial Infarction
$784,206Nikolaos G Frangogiannis · Albert Einstein College Of Medicine · R01 · FY2025 · HL
Impact of microbiota on AIDS-Kaposiâs sarcoma development and therapy
$784,127Shou-Jiang Gao · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Mechanisms and interventions addressing accelerated cardiovascular disease risk in women with endometriosis
$784,116Lacy M. Alexander · Pennsylvania State University, The · R01 · FY2022 · HL
Phase 2 placebo-controlled randomized trial of LACTIN-V (Lactobacillus crispatus CTV-05) among women at high risk of HIV acquisition in Durban, South Africa
$784,076Craig R Cohen · University Of California, San Francisco · R01 · FY2019 · HD
Role of Th17 in Severe and Recurrent C. difficile Infection
$784,076William A Petri · University Of Virginia · R01 · FY2022 · AI
Systems investigation of vaccine responses in aging and frailty
$784,057Albert C Shaw · Yale University · U19 · FY2024 · AI
Role of cellular senescence in cardiovascular aging
$784,023Simon Melov · Buck Institute For Research On Aging · R01 · FY2020 · AG
Developing novel therapies to improve blood stem cell transplantation outcomes
$783,992Ramiro Garzon · Ohio State University · R01 · FY2022 · HL
Local B-1 Regulation of Atherosclerosis
$783,960Coleen A McNamara · University Of Virginia · R01 · FY2017 · HL
5/9 Predictors and Mechanisms of Conversion to Psychosis
$783,936Diana O. Perkins · Univ Of North Carolina Chapel Hill · U01 · FY2018 · MH
Mechanisms of atherosclerotic cardiovascular complications in COVID19
$783,846Chiara Giannarelli · New York University School Of Medicine · R01 · FY2023 · HL
Mechanisms of atherosclerotic cardiovascular complications
$783,846Chiara Giannarelli · New York University School Of Medicine · R01 · FY2025 · HL
Involvement Of Human Viruses Associated With Chronic Neurologic Disease
$783,838Steven Jacobson · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS